These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 10078533)
21. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337 [TBL] [Abstract][Full Text] [Related]
22. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation. Truckenmiller ME; Bonneau RH; Norbury CC Brain Behav Immun; 2006 May; 20(3):210-8. PubMed ID: 16504465 [TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573 [TBL] [Abstract][Full Text] [Related]
24. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells. Hiltbold EM; Alter MD; Ciborowski P; Finn OJ Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817 [TBL] [Abstract][Full Text] [Related]
25. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule. Hetttihewa LM Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436 [TBL] [Abstract][Full Text] [Related]
26. Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. Balmelli C; Ruggli N; McCullough K; Summerfield A J Leukoc Biol; 2005 Jun; 77(6):923-33. PubMed ID: 15767291 [TBL] [Abstract][Full Text] [Related]
27. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. Rock KL; Rothstein L; Gamble S; Fleischacker C J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476 [TBL] [Abstract][Full Text] [Related]
28. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797 [TBL] [Abstract][Full Text] [Related]
29. Similar immune responses and antitumor effects of murine dendritic cells loaded with either exogenous or endogenous-synthesized protein. Lacave R; Masurier C; Guigon M; Lemoine FM; Klatzmann D; Colombo BM Int J Oncol; 2003 Dec; 23(6):1747-53. PubMed ID: 14612950 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166 [TBL] [Abstract][Full Text] [Related]
31. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. Kim DT; Mitchell DJ; Brockstedt DG; Fong L; Nolan GP; Fathman CG; Engleman EG; Rothbard JB J Immunol; 1997 Aug; 159(4):1666-8. PubMed ID: 9257826 [TBL] [Abstract][Full Text] [Related]
32. TAP1-independent loading of class I molecules by exogenous viral proteins. Bachmann MF; Oxenius A; Pircher H; Hengartner H; Ashton-Richardt PA; Tonegawa S; Zinkernagel RM Eur J Immunol; 1995 Jun; 25(6):1739-43. PubMed ID: 7615001 [TBL] [Abstract][Full Text] [Related]
33. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Doe B; Selby M; Barnett S; Baenziger J; Walker CM Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8578-83. PubMed ID: 8710913 [TBL] [Abstract][Full Text] [Related]
34. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway. Zhou F; Huang L J Drug Target; 1995; 3(2):91-109. PubMed ID: 7496732 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. Sigal LJ; Rock KL J Exp Med; 2000 Oct; 192(8):1143-50. PubMed ID: 11034604 [TBL] [Abstract][Full Text] [Related]
36. Class I antigen presentation. Jelachich ML; Biddison WE Year Immunol; 1989; 4():41-58. PubMed ID: 2522701 [No Abstract] [Full Text] [Related]
37. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. Lenz LL; Butz EA; Bevan MJ J Exp Med; 2000 Oct; 192(8):1135-42. PubMed ID: 11034603 [TBL] [Abstract][Full Text] [Related]
38. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Starck SR; Jiang V; Pavon-Eternod M; Prasad S; McCarthy B; Pan T; Shastri N Science; 2012 Jun; 336(6089):1719-23. PubMed ID: 22745432 [TBL] [Abstract][Full Text] [Related]
39. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Cerundolo V; Alexander J; Anderson K; Lamb C; Cresswell P; McMichael A; Gotch F; Townsend A Nature; 1990 May; 345(6274):449-52. PubMed ID: 2342577 [TBL] [Abstract][Full Text] [Related]
40. Heat shock proteins and immunity: application of hyperthermia for immunomodulation. Torigoe T; Tamura Y; Sato N Int J Hyperthermia; 2009 Dec; 25(8):610-6. PubMed ID: 20021222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]